The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neuroleptics Market Research Report 2025
Synopsis
Neuroleptics are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psychotic disorders. Antipsychotics are usually effective in relieving symptoms of psychosis in the short term.
The global Neuroleptics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Neuroleptics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroleptics.
Report Scope
The Neuroleptics market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuroleptics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuroleptics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Pfizer
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
GSK
Allergan
Segment by Type
First Generation
Second Generation
Third Generation
Segment by Application
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neuroleptics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neuroleptics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Neuroleptics are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psychotic disorders. Antipsychotics are usually effective in relieving symptoms of psychosis in the short term.
The global Neuroleptics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Neuroleptics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroleptics.
Report Scope
The Neuroleptics market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuroleptics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuroleptics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Pfizer
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
GSK
Allergan
Segment by Type
First Generation
Second Generation
Third Generation
Segment by Application
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neuroleptics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neuroleptics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Neuroleptics Market Overview
1.1 Product Overview and Scope of Neuroleptics
1.2 Neuroleptics Segment by Type
1.2.1 Global Neuroleptics Market Value Comparison by Type (2024-2030)
1.2.2 First Generation
1.2.3 Second Generation
1.2.4 Third Generation
1.3 Neuroleptics Segment by Application
1.3.1 Global Neuroleptics Market Value by Application: (2024-2030)
1.3.2 Schizophrenia
1.3.3 Bipolar Disorder
1.3.4 Unipolar Depression
1.3.5 Dementia
1.3.6 Others
1.4 Global Neuroleptics Market Size Estimates and Forecasts
1.4.1 Global Neuroleptics Revenue 2019-2030
1.4.2 Global Neuroleptics Sales 2019-2030
1.4.3 Global Neuroleptics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neuroleptics Market Competition by Manufacturers
2.1 Global Neuroleptics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neuroleptics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neuroleptics Average Price by Manufacturers (2019-2024)
2.4 Global Neuroleptics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neuroleptics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neuroleptics, Product Type & Application
2.7 Neuroleptics Market Competitive Situation and Trends
2.7.1 Neuroleptics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neuroleptics Players Market Share by Revenue
2.7.3 Global Neuroleptics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neuroleptics Retrospective Market Scenario by Region
3.1 Global Neuroleptics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neuroleptics Global Neuroleptics Sales by Region: 2019-2030
3.2.1 Global Neuroleptics Sales by Region: 2019-2024
3.2.2 Global Neuroleptics Sales by Region: 2025-2030
3.3 Global Neuroleptics Global Neuroleptics Revenue by Region: 2019-2030
3.3.1 Global Neuroleptics Revenue by Region: 2019-2024
3.3.2 Global Neuroleptics Revenue by Region: 2025-2030
3.4 North America Neuroleptics Market Facts & Figures by Country
3.4.1 North America Neuroleptics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neuroleptics Sales by Country (2019-2030)
3.4.3 North America Neuroleptics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neuroleptics Market Facts & Figures by Country
3.5.1 Europe Neuroleptics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neuroleptics Sales by Country (2019-2030)
3.5.3 Europe Neuroleptics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neuroleptics Market Facts & Figures by Country
3.6.1 Asia Pacific Neuroleptics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neuroleptics Sales by Country (2019-2030)
3.6.3 Asia Pacific Neuroleptics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neuroleptics Market Facts & Figures by Country
3.7.1 Latin America Neuroleptics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neuroleptics Sales by Country (2019-2030)
3.7.3 Latin America Neuroleptics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neuroleptics Market Facts & Figures by Country
3.8.1 Middle East and Africa Neuroleptics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neuroleptics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neuroleptics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Neuroleptics Sales by Type (2019-2030)
4.1.1 Global Neuroleptics Sales by Type (2019-2024)
4.1.2 Global Neuroleptics Sales by Type (2025-2030)
4.1.3 Global Neuroleptics Sales Market Share by Type (2019-2030)
4.2 Global Neuroleptics Revenue by Type (2019-2030)
4.2.1 Global Neuroleptics Revenue by Type (2019-2024)
4.2.2 Global Neuroleptics Revenue by Type (2025-2030)
4.2.3 Global Neuroleptics Revenue Market Share by Type (2019-2030)
4.3 Global Neuroleptics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neuroleptics Sales by Application (2019-2030)
5.1.1 Global Neuroleptics Sales by Application (2019-2024)
5.1.2 Global Neuroleptics Sales by Application (2025-2030)
5.1.3 Global Neuroleptics Sales Market Share by Application (2019-2030)
5.2 Global Neuroleptics Revenue by Application (2019-2030)
5.2.1 Global Neuroleptics Revenue by Application (2019-2024)
5.2.2 Global Neuroleptics Revenue by Application (2025-2030)
5.2.3 Global Neuroleptics Revenue Market Share by Application (2019-2030)
5.3 Global Neuroleptics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Neuroleptics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Neuroleptics Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Neuroleptics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Neuroleptics Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Neuroleptics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly Neuroleptics Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Corporation Information
6.4.2 Bristol-Myers Squibb Description and Business Overview
6.4.3 Bristol-Myers Squibb Neuroleptics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bristol-Myers Squibb Neuroleptics Product Portfolio
6.4.5 Bristol-Myers Squibb Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Neuroleptics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Neuroleptics Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Neuroleptics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GSK Neuroleptics Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Allergan
6.6.1 Allergan Corporation Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Neuroleptics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allergan Neuroleptics Product Portfolio
6.7.5 Allergan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neuroleptics Industry Chain Analysis
7.2 Neuroleptics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neuroleptics Production Mode & Process
7.4 Neuroleptics Sales and Marketing
7.4.1 Neuroleptics Sales Channels
7.4.2 Neuroleptics Distributors
7.5 Neuroleptics Customers
8 Neuroleptics Market Dynamics
8.1 Neuroleptics Industry Trends
8.2 Neuroleptics Market Drivers
8.3 Neuroleptics Market Challenges
8.4 Neuroleptics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Neuroleptics Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Neuroleptics Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Neuroleptics Market Competitive Situation by Manufacturers in 2023
Table 4. Global Neuroleptics Sales (K MT) of Key Manufacturers (2019-2024)
Table 5. Global Neuroleptics Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Neuroleptics Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Neuroleptics Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Neuroleptics Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Neuroleptics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Neuroleptics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neuroleptics, Product Type & Application
Table 12. Global Key Manufacturers of Neuroleptics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neuroleptics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroleptics as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neuroleptics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Neuroleptics Sales by Region (2019-2024) & (K MT)
Table 18. Global Neuroleptics Sales Market Share by Region (2019-2024)
Table 19. Global Neuroleptics Sales by Region (2025-2030) & (K MT)
Table 20. Global Neuroleptics Sales Market Share by Region (2025-2030)
Table 21. Global Neuroleptics Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Neuroleptics Revenue Market Share by Region (2019-2024)
Table 23. Global Neuroleptics Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Neuroleptics Revenue Market Share by Region (2025-2030)
Table 25. North America Neuroleptics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Neuroleptics Sales by Country (2019-2024) & (K MT)
Table 27. North America Neuroleptics Sales by Country (2025-2030) & (K MT)
Table 28. North America Neuroleptics Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Neuroleptics Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Neuroleptics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Neuroleptics Sales by Country (2019-2024) & (K MT)
Table 32. Europe Neuroleptics Sales by Country (2025-2030) & (K MT)
Table 33. Europe Neuroleptics Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Neuroleptics Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Neuroleptics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Neuroleptics Sales by Region (2019-2024) & (K MT)
Table 37. Asia Pacific Neuroleptics Sales by Region (2025-2030) & (K MT)
Table 38. Asia Pacific Neuroleptics Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Neuroleptics Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Neuroleptics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Neuroleptics Sales by Country (2019-2024) & (K MT)
Table 42. Latin America Neuroleptics Sales by Country (2025-2030) & (K MT)
Table 43. Latin America Neuroleptics Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Neuroleptics Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Neuroleptics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Neuroleptics Sales by Country (2019-2024) & (K MT)
Table 47. Middle East & Africa Neuroleptics Sales by Country (2025-2030) & (K MT)
Table 48. Middle East & Africa Neuroleptics Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Neuroleptics Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Neuroleptics Sales (K MT) by Type (2019-2024)
Table 51. Global Neuroleptics Sales (K MT) by Type (2025-2030)
Table 52. Global Neuroleptics Sales Market Share by Type (2019-2024)
Table 53. Global Neuroleptics Sales Market Share by Type (2025-2030)
Table 54. Global Neuroleptics Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Neuroleptics Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Neuroleptics Revenue Market Share by Type (2019-2024)
Table 57. Global Neuroleptics Revenue Market Share by Type (2025-2030)
Table 58. Global Neuroleptics Price (USD/MT) by Type (2019-2024)
Table 59. Global Neuroleptics Price (USD/MT) by Type (2025-2030)
Table 60. Global Neuroleptics Sales (K MT) by Application (2019-2024)
Table 61. Global Neuroleptics Sales (K MT) by Application (2025-2030)
Table 62. Global Neuroleptics Sales Market Share by Application (2019-2024)
Table 63. Global Neuroleptics Sales Market Share by Application (2025-2030)
Table 64. Global Neuroleptics Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Neuroleptics Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Neuroleptics Revenue Market Share by Application (2019-2024)
Table 67. Global Neuroleptics Revenue Market Share by Application (2025-2030)
Table 68. Global Neuroleptics Price (USD/MT) by Application (2019-2024)
Table 69. Global Neuroleptics Price (USD/MT) by Application (2025-2030)
Table 70. Johnson & Johnson Corporation Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Neuroleptics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Johnson & Johnson Neuroleptics Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Neuroleptics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Pfizer Neuroleptics Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Neuroleptics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Eli Lilly Neuroleptics Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Bristol-Myers Squibb Corporation Information
Table 86. Bristol-Myers Squibb Description and Business Overview
Table 87. Bristol-Myers Squibb Neuroleptics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Bristol-Myers Squibb Neuroleptics Product
Table 89. Bristol-Myers Squibb Recent Developments/Updates
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Neuroleptics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. AstraZeneca Neuroleptics Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. GSK Corporation Information
Table 96. GSK Description and Business Overview
Table 97. GSK Neuroleptics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. GSK Neuroleptics Product
Table 99. GSK Recent Developments/Updates
Table 100. Allergan Corporation Information
Table 101. Allergan Description and Business Overview
Table 102. Allergan Neuroleptics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Allergan Neuroleptics Product
Table 104. Allergan Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Neuroleptics Distributors List
Table 108. Neuroleptics Customers List
Table 109. Neuroleptics Market Trends
Table 110. Neuroleptics Market Drivers
Table 111. Neuroleptics Market Challenges
Table 112. Neuroleptics Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neuroleptics
Figure 2. Global Neuroleptics Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Neuroleptics Market Share by Type in 2023 & 2030
Figure 4. First Generation Product Picture
Figure 5. Second Generation Product Picture
Figure 6. Third Generation Product Picture
Figure 7. Global Neuroleptics Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Neuroleptics Market Share by Application in 2023 & 2030
Figure 9. Schizophrenia
Figure 10. Bipolar Disorder
Figure 11. Unipolar Depression
Figure 12. Dementia
Figure 13. Others
Figure 14. Global Neuroleptics Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Neuroleptics Market Size (2019-2030) & (US$ Million)
Figure 16. Global Neuroleptics Sales (2019-2030) & (K MT)
Figure 17. Global Neuroleptics Average Price (USD/MT) & (2019-2030)
Figure 18. Neuroleptics Report Years Considered
Figure 19. Neuroleptics Sales Share by Manufacturers in 2023
Figure 20. Global Neuroleptics Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Neuroleptics Players: Market Share by Revenue in 2023
Figure 22. Neuroleptics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Neuroleptics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Neuroleptics Sales Market Share by Country (2019-2030)
Figure 25. North America Neuroleptics Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Neuroleptics Sales Market Share by Country (2019-2030)
Figure 29. Europe Neuroleptics Revenue Market Share by Country (2019-2030)
Figure 30. Germany Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Neuroleptics Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Neuroleptics Revenue Market Share by Region (2019-2030)
Figure 37. China Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Neuroleptics Sales Market Share by Country (2019-2030)
Figure 48. Latin America Neuroleptics Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Neuroleptics Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Neuroleptics Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Neuroleptics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Neuroleptics by Type (2019-2030)
Figure 58. Global Revenue Market Share of Neuroleptics by Type (2019-2030)
Figure 59. Global Neuroleptics Price (USD/MT) by Type (2019-2030)
Figure 60. Global Sales Market Share of Neuroleptics by Application (2019-2030)
Figure 61. Global Revenue Market Share of Neuroleptics by Application (2019-2030)
Figure 62. Global Neuroleptics Price (USD/MT) by Application (2019-2030)
Figure 63. Neuroleptics Value Chain
Figure 64. Neuroleptics Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
